Can you believe the San Diego Biotechnology Network is three years old now? We held our first SDBN event in November of 2008, and our objective was to improve networking opportunities for local biotech professionals. […]
What a great turnout last week!? Thanks to all who attended SDBN’s first Happy Hour event, and thanks to our sponsor Avitus Group. As always we enjoyed seeing many familiar as well as new faces […]
Please join us for the Bioengineering Graduate Society’s 17th Annual Breakfast with Industry. Network with current bioengineering graduate students and faculty over a catered breakfast buffet and listen to this year’s keynote speaker: Dr. Gail […]
16th Annual INCOSE Region II Fall Mini-Conference Systems Engineering: The Bridge between the Aerospace and Medical Industries General Information Attend this day of stimulating thought and discussion centered around the questions: How is classical Systems […]
You may know that San Diego is home to at least 36 fantastic breweries. Green Flash Brewery is a great example, and we are lucky that they opened a 4,000 square foot tasting room in […]
You may know that San Diego is home to at least 36 fantastic breweries. Green Flash Brewery is a great example, and we are lucky that they opened a 4,000 square foot tasting room in […]
Eric Schadt’s career as a scientist has been focused on unlocking genetic cues to common human diseases such as diabetes and obesity. He is the chief scientific officer of Pacific Biosciences,…
[[Click headline to continue reading.]] […]
Who says you can’t be smart, witty, or say anything of substance in 140 characters or less? Alnylam Pharmaceuticals CEO John Maraganore had a zinger ready yesterday as Apple’s…
[[Click headline to continue reading.]] […]
SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur… […]
SAN DIEGO, CA–(Marketwire – Sep 29, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, has initiated dosing in its PEDigree clinical trial where iSONEPT is being investigated as a treatment for retinal … […]
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes
